These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The chemotherapy of prostatic adenocarcinoma. Torti FM; Carter SK Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675 [TBL] [Abstract][Full Text] [Related]
24. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III. Drago JR J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207 [TBL] [Abstract][Full Text] [Related]
26. Chemotherapy in the treatment of Hodgkin's disease. Canellos GP; Come SE; Skarin AT Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191 [No Abstract] [Full Text] [Related]
27. The chemotherapy of urologic cancer. Carter SK; Wasserman TH Cancer; 1975 Aug; 36(2):729-47. PubMed ID: 125624 [TBL] [Abstract][Full Text] [Related]
28. Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804. Ginsberg SJ; Crooke ST; Bloomfield CD; Peterson B; Kennedy BJ; Blom J; Ellison RR; Pajak TF; Gottlieb AJ Cancer; 1982 Apr; 49(7):1346-52. PubMed ID: 6174203 [TBL] [Abstract][Full Text] [Related]
29. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP). Carmo-Pereira J; Costa FO; Henriques E Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020 [TBL] [Abstract][Full Text] [Related]
30. The role of chemotherapy in the treatment of lung cancer. Selawry OS Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488 [No Abstract] [Full Text] [Related]
31. Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study. Jones SE; Haut A; Weick JK; Wilson HE; Grozea P; Fabian CJ; McKelvey E; Byrne GE; Hartsock R; Dixon DO; Coltman CA Cancer; 1983 Apr; 51(8):1339-47. PubMed ID: 6186355 [No Abstract] [Full Text] [Related]
32. Advances in chemotherapy for large cell lymphoma. Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781 [TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study. Grozea PN; Jones SE; McKelvey EM; Coltman CA; Fisher R; Haskins CL Cancer Treat Rep; 1979 Apr; 63(4):647-53. PubMed ID: 87277 [TBL] [Abstract][Full Text] [Related]
34. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma. Cornfield DB; Rossman RE South Med J; 1982 Feb; 75(2):248-9. PubMed ID: 7058376 [No Abstract] [Full Text] [Related]
35. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma. Rosenthal CJ; Ritter S; Platica O Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350 [No Abstract] [Full Text] [Related]
36. Cytokinetic evaluation of the four-drug combination of bleomycin, vincristine, mitomycin C, and methotrexate (BOMM) in cultured Burkitt's lymphoma cells and human bone marrow. Wheeler RH; Clauw DJ; O'Toole TE; Ensminger WD Cancer; 1982 Nov; 50(10):1993-9. PubMed ID: 6181861 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr). Drago JR; Goldman LB; Gershwin ME Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771 [TBL] [Abstract][Full Text] [Related]
38. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma. Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023 [TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for advanced cutaneous T-cell lymphomas. Raafat J; Oster MW; Lo Gerfo P; Edelson RL Cancer Treat Rep; 1980; 64(12):1371-4. PubMed ID: 6162558 [TBL] [Abstract][Full Text] [Related]
40. Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma. Lupera H; Droz JP; Piot G; Lapleige P; Fargeot P; Theodore C Oncology; 1989; 46(6):372-4. PubMed ID: 2587004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]